ASTELLAS PHARMA INDIA PRIVATE LIMITED
CIN: U85192MH2008FTC188194
ASTELLAS PHARMA INDIA PRIVATE LIMITED (CIN: U85192MH2008FTC188194) is a Private company incorporated on 14 Nov 2008. It is classified as subsidiary of company incorporated outside India and is registered at Registrar of Companies, Mumbai. Its authorized share capital is Rs. 500000000.00 and its paid up capital is Rs. 336923090.00.
ASTELLAS PHARMA INDIA PRIVATE LIMITED's Annual General Meeting (AGM) was last held on 26 Sep 2023. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2023-03-31.ASTELLAS PHARMA INDIA PRIVATE LIMITED's NIC code is 8519 (which is part of its CIN). As per the NIC code, it is inolved in Other human health activities [Includes all activities for human health other than by hospitals and medical doctors and dentists].
Directors of ASTELLAS PHARMA INDIA PRIVATE LIMITED are MEHMET ALP ATAY, SAMPADA ANANDKUMAR GOSAVI, and RICARDO FERNANDO BEZERRA LEITE.
ASTELLAS PHARMA INDIA PRIVATE LIMITED's Corporate Identification Number (CIN) is U85192MH2008FTC188194 and its registration number is 188194. Users may contact ASTELLAS PHARMA INDIA PRIVATE LIMITED on its Email address - [email protected]. Registered address of ASTELLAS PHARMA INDIA PRIVATE LIMITED is UNIT NO. 301, 'C & B SQUARE',CTS NO. 95 A,127 ANDHERI KURLA RD, VILLAGE CHAKALA, ANDHE RI (EAST) , MUMBAI, Maharashtra, India - 400069.
Current status of ASTELLAS PHARMA INDIA PRIVATE LIMITED is - Active.
Basic Information
- CIN
- Name
- Listed on Stock Exchange
- Company Status
- ROC
- Registration Number
- Company Category
- Company Sub Category
- Class of Company
- Date of Incorporation
- Age of Company
- Activity
- Number of Members
Annual Compliance Status
- Date of Last Annual General Meeting
- Date of Last Filed Balance Sheet
Key Numbers
- Authorised Share Capital
- Paid-up Share Capital
- Total Assets
- Revenue
- Profit
- Salaries & Other Employee Benefit Expenses
Want to see how this company compares within its industry or analyse broader market trends?
Explore Prime Research for Industry & Economic InsightsPrevious Names
Previous CINs
ZaubaCorp's company report for ASTELLAS PHARMA INDIA includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.
Purchase ReportAll companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.
Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.
Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of ASTELLAS PHARMA INDIA
Purchase full report of ASTELLAS PHARMA INDIA
Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if ASTELLAS PHARMA INDIA pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.
| Filing Type | As On | Amount Due to MSME | Current Liabilities | Ratio to Current Liabilities | Reasons for Delay |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.
Director Complaints
| Date | DIN | Cessation Date | Cessation Reason | Complaint |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serious Complaints
| Date | Complaint | Other Details |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Complaints & Other Complaints
| Date | Complaint Type | Complaint Sub Type | Particulars of Secutiries | Period | Complaint | Other Details |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Directors & Key Managerial Personnel of ASTELLAS PHARMA INDIA
| DIN | Director Name | Designation | Appointment Date |
|---|---|---|---|
| 08806422 | MEHMET ALP ATAY | Director | 2020-10-30 |
| 10046545 | SAMPADA ANANDKUMAR GOSAVI | Managing Director | 2023-04-06 |
| 10471247 | RICARDO FERNANDO BEZERRA LEITE | Additional Director | 2024-02-07 |
Past Directors & Key Managerial Personnel of ASTELLAS PHARMA INDIA
| DIN | Director Name | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| 08388621 | DAOWEN SOON | Additional Director | - | 2021-09-28 |
| 08388621 | DAOWEN SOON | Director | - | 2024-02-02 |
| 07796678 | YASUHIRO NAKAGIRI | Additional Director | - | 2017-04-28 |
| 07796678 | YASUHIRO NAKAGIRI | Director | - | 2020-12-23 |
| 07796678 | YASUHIRO NAKAGIRI | Managing Director | - | 2020-06-19 |
| 08192431 | TAKASHI MATSUKI | Additional Director | - | 2018-09-26 |
| 08192431 | TAKASHI MATSUKI | Director | - | 2020-03-31 |
| 08806422 | MEHMET ALP ATAY | Additional Director | - | 2020-10-30 |
| 05170758 | AKIRA KAMIMURA | Additional Director | - | 2012-08-03 |
| 05170758 | AKIRA KAMIMURA | Director | - | 2015-01-13 |
| 06967539 | KEITA MASUJIMA . | Director | - | 2017-08-07 |
| 07857624 | HIROSHI HAMAGUCHI | Additional Director | - | 2017-09-29 |
| 07857624 | HIROSHI HAMAGUCHI | Director | - | 2017-12-31 |
| 08771174 | SANJAY SHARMA | Additional Director | - | 2020-06-24 |
| 08771174 | SANJAY SHARMA | Managing Director | - | 2022-04-30 |
| 10046545 | SAMPADA ANANDKUMAR GOSAVI | Additional Director | - | 2023-03-24 |
| 10046545 | SAMPADA ANANDKUMAR GOSAVI | Managing Director | - | 2023-09-25 |
| 03643734 | ISAMU SAKURAI | Director | - | 2019-03-01 |
| 03643734 | ISAMU SAKURAI | Managing Director | - | 2014-10-01 |
| 06576587 | YOSHITAKA KOKETSU | Additional Director | - | 2013-09-24 |
| 06576587 | YOSHITAKA KOKETSU | Director | - | 2014-04-01 |
| 06988793 | MITSURU TADA | Additional Director | - | 2014-09-30 |
| 06988793 | MITSURU TADA | Director | - | 2019-03-01 |
| 06988793 | MITSURU TADA | Managing Director | - | 2017-04-28 |
| 08472622 | TAICHIRO SEIKE | Additional Director | - | 2019-09-23 |
| 08472622 | TAICHIRO SEIKE | Director | - | 2020-12-23 |
| 09745567 | RAHUL BALKRISHNA DAVE | Additional Director | - | 2022-09-30 |
| 09745567 | RAHUL BALKRISHNA DAVE | Director | - | 2023-03-25 |
| 07097180 | NAOHISA KOSHIISHI | Director | - | 2017-08-07 |
| 07879053 | HONG PEI | Additional Director | - | 2017-09-29 |
| 07879053 | HONG PEI | Director | - | 2019-12-31 |
| 08109146 | SURABHI SHARMA | Company Secretary | - | 2017-12-19 |
Other Directorships of DAOWEN SOON
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| HOYA MEDICAL INDIA PRIVATE LIMITED | U51909DL2011FTC226966 | Additional Director | - | 2019-09-28 |
| HOYA MEDICAL INDIA PRIVATE LIMITED | U51909DL2011FTC226966 | Director | - | 2020-08-28 |
Other Directorships of YASUHIRO NAKAGIRI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| ADCOCK INGRAM LIMITED | U24232KA2007PLC042361 | Additional Director | 2024-06-20 | Ongoing |
| ADCOCK INGRAM PHARMA PRIVATE LIMITED | U24299KA2021PTC148184 | Additional Director | 2024-06-20 | Ongoing |
| ORGANISATION OF PHARMACEUTICAL PRODUCERS OF INDIA | U91120MH1965GAP013389 | Director | - | 2020-03-31 |
Other Directorships of TAKASHI MATSUKI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of MEHMET ALP ATAY
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of AKIRA KAMIMURA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of KEITA MASUJIMA .
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of HIROSHI HAMAGUCHI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of SANJAY SHARMA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED | U24230MH2004FTC147232 | Additional Director | - | 2022-09-27 |
| BRISTOL-MYERS SQUIBB INDIA PRIVATE LIMITED | U24230MH2004FTC147232 | Director | 2022-05-24 | Ongoing |
| ORGANISATION OF PHARMACEUTICAL PRODUCERS OF INDIA | U91120MH1965GAP013389 | Director | - | 2022-04-30 |
Other Directorships of SAMPADA ANANDKUMAR GOSAVI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of RICARDO FERNANDO BEZERRA LEITE
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of ISAMU SAKURAI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of YOSHITAKA KOKETSU
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of MITSURU TADA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| ORGANISATION OF PHARMACEUTICAL PRODUCERS OF INDIA | U91120MH1965GAP013389 | Director | - | 2017-03-31 |
Other Directorships of TAICHIRO SEIKE
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of RAHUL BALKRISHNA DAVE
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of NAOHISA KOSHIISHI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of HONG PEI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|
Other Directorships of SURABHI SHARMA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| UNIVERSAL WEATHER AND AVIATION INDIA PRIVATE LIMITED | U63040DL2006PTC154671 | Additional Director | - | 2018-09-28 |
| WINDSOR CORPORATE TOWER PRIVATE LIMITED | U70102DL2015PTC283789 | Company Secretary | - | 2019-01-31 |
| CIN | Company Name | Company Address |
|---|
| Charge ID | Charge Creation Date | Charge Modification Date | Charge Closure Date | Assets Under Charge | Amount | Charge Holder |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Email ID
- Website
- Address
This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.
| Financial Year | Business Activity Code | Business Activity Description | Percentage of Turnover |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.
| 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Download Audited Financials | |||||||||||||
| EQUITY AND LIABILITIES | |||||||||||||
| Shareholder's funds | |||||||||||||
| Share Capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reserves & Surplus |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Money Received Against Share Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Application Money Pending Allotment |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-current Liabilities | |||||||||||||
| Long-term borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred tax liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Long Term Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long Term Provisions |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current Liabilities | |||||||||||||
| Short-term borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade Payables |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Current Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short Term Provisions |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Equity and Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASSETS | |||||||||||||
| Non-current Assets | |||||||||||||
| Fixed Assets | |||||||||||||
| Tangible Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Work In Progress |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible Assets Under Development |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-current Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred Tax Assets (net) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term Loans & Advances |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Non-current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current Assets | |||||||||||||
| Current Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Inventories |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade receivables |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash & Cash Equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-term Loans & Advances |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.
| 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Download Audited Financials | |||||||||||||
| REVENUE FROM OPERATIONS | |||||||||||||
| Domestic Turnover | |||||||||||||
| Sale of Goods Manufactured |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Goods Traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Supple of Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Export Turnover | |||||||||||||
| Sale of Goods Manufactured |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Goods Traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale or Supply of Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Revenue From Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| EXPENSES | |||||||||||||
| Cost of Materials Consumed |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchases of Stock in Trade |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in Inventories of |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Finished Goods |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Work in Progress |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock in Trade |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee benefit Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Managerial Remuneration |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment to Auditors |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Insurance Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Power & Fuel |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Finance Cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation & Amortization Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Exceptional Items, Extraordinary Items and Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exceptional Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Extraordinary items and Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tax Expense | |||||||||||||
| Current Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit/Loss after Tax from Continuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit/Loss after Tax from Discontinuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tax Expense of Discontinuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Profit/Loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per Equity Share (EPS) before Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per Equity Share (EPS) after Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.
| Date of Allotment | Securities Alloted | Terms | Number of Securities | Nominal Amount | Premium Amount Due & Payable | Premium Amount Paid | Total Discount | Amount to be Paid on Calls (Excluding Premium) | Attachments |
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.
| Company Identifier | Name | Percentage of Shares Held |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains list of board resolutions reported by the company to the Registrar of Companies.
| Date of Filing | Date of Dispatch of Notice | Date of Passing Resolution | Section (Companies Act 2013) | Section (Companies Act 1956) | Subject Matter of Resolution | Resolution Agreed By | Resolution Type | Additional Documents |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.
| Financial Year | Name of Auditor or Firm | PAN of Auditor or Firm | Membership Number / Registration Number | Name of Auditor Signing Report | Membership Number of Auditor Signing Report |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As on: 2026-07-13
Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.